Brief: Jiangxi Institute Of Biological Products Posts HY Adjusted Net Profit of RMB38.7 MLN
31/08/2026 11:27
BRIEF-Jiangxi Institute Of Biological Products Posts HY Adjusted Net Profit of RMB38.7 MLN Aug 31 (Reuters) - Jiangxi Institute of Biological Products Inc 6915.HK:
REVENUE FOR SIX MONTHS ENDED JUNE 30, 2026 DOWN 16.5% TO RMB83.3 MILLION
ADJUSTED NET PROFIT FOR SIX MONTHS ENDED JUNE 30, 2026 DOWN 21.7% TO RMB38.7 MILLION
NO DIVIDENDS WERE PAID, DECLARED OR PROPOSED DURING HY
Further company coverage: 6915.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jiangxi Institute of Biological Products
See all newsBrief: Jiangxi Institute Of Biological Products Posts HY Adjusted Net Profit of RMB38.7 MLN
Brief: Jiangxi Institute Of Biological Products Commences Veterinary Tetanus Antitoxin Production
Brief: Jiangxi Institute Of Biological Products Says Unit Obtains Approval Certificate For Veterinary Tetanus Antitoxin
Guangdong True Health, Zhejiang Laifual, Hangzhou Qiandaohu jump in HK debut
Brief: Jiangxi Institute Of Biological Products Sets Final Offer Price Under Global Offering At HK$11.2 Per H Share